Skip to content

Post-Rollout Surges in Hospitalizations and Chronic Conditions

Day 3 · 0:37:24 · Deanna McLeod · Carol Messenger

  • 🏥 Hospital trends show sharp rises in infections, maternal/parasitic disease, immune disorders and iron-deficiency anemia after vaccine rollout.
  • ⚠️ Drug adverse effects including anaphylaxis, Bell’s palsy and pulmonary embolisms spiked, the latter later treated with costly patented anticoagulants.
  • 🩸 Ongoing immune dysregulation leaves the population less able to fight infection through 2025.

Administrative data reveal broad excess morbidity timed to vaccination campaigns.

← 14-Day Status Delay Masks Early Injuries and Infections | Reproductive Harms: Ovarian Inflammation and Miscarriages →

Transcript

Deanna McLeod · 0:37:24

Okay, so here's another— this is basically hospital care trend data. I just threw a lot of these in there because I wanted to show, but you can actually see you can see that the trend for infection following immunization was going down. And then you have the rollout of the shots and then you have this dramatic jump up. The two guardrails there are the confidence intervals, which means it's not due to chance. Over here we have maternal infection and parasitic disease. So you can see that something's happening to their immune systems because in 2021 you have this absolute dramatic increase in maternal infections and parasitic diseases, which, you know, it's a category. And then in 2022, it continues to go up. So we had a really big push to try and vaccinate pregnant women, and this is some of the things that were happening, is that they're now increasingly susceptible to infection. There's also impacts on immunology and hematology. So after the COVID-19 rollout, you can see on the left-hand side that there's this immunity disorder where you actually become more susceptible to infections that increases over time.

Deanna McLeod · 0:38:28

So there's a jump right when they roll it out but you can see at the far right, which is July 2025, there's this increase. So what we're seeing is the population's immune system is becoming less able to fight infection. We have iron deficiency anemia. I added this slide in last night because there were a lot of people who testified who basically said, "I'm suffering from incredible fatigue." So we know that the ITT is a side effect of the vaccine, which basically means that you have your immune system either causes clotting or bleeding. It basically dysregulates your ability to, um, for your blood to work in terms of clotting and bleeding. The long and the short of it is, is that there could be chronic bleeding or it could be doing something directly to the platelets. But if you actually look at this, iron deficiency anemia skyrocketed the moment that you rolled out the vaccine, and it's continuing to climb to the right. It's difficult for us to know whether these are people who are getting boosted, or it's difficult for us to know if, if, um, you know, what exactly— whether this is a result of bleeding.

Deanna McLeod · 0:39:31

But basically, this would cause chronic fatigue. So, and the numbers are outstanding. If you look at the left-hand side, you can see that pre-COVID, maybe you had 200 people like this per 100,000. And now on, on the right-hand side, we're getting close to 325 per 100,000. So that's a dramatic increase in iron deficiency anemia.

Carol Messenger · 0:39:56

This is—.

Deanna McLeod · 0:39:57

Somebody mentioned yesterday about anaphylaxis. You can see here that this is drug adverse effects, which would include anaphylaxis. Pre-COVID, it was pretty standard. The rollout of the vaccine, and you can see those jumps. That is one of those kind people's mothers dying, that jump up there. Or maybe more, and then coming back down again. So the rollout, especially that first dose, was incredibly toxic and caused anaphylaxis. Anaphylaxis is life-threatening. So again, you have to ask yourself, you have COVID, which is not life-threatening for the majority of the population, and then you give them a dose of a product that causes an immediate reaction, which is notable here. And looking at what, 160 per 100,000 people are getting an anaphylactic reaction or something along those lines after their COVID shot, and we're calling this good. Bell's palsy, we had some people reporting that. So again, very standard leading up, there's a, a little bit of a blip, and then now you can see that the line would be where normal is, and we are hovering well above the line, meaning that this is an ongoing issue.

Deanna McLeod · 0:41:08

People are suffering from Bell's palsy and it's going out to 2025. This is not just a transitory reaction. Pulmonary embolisms, you can see that there's a peak right when they rolled it out in June 2021. It kind of goes down afterwards because believe it or not, Pfizer has a new drug called Eliquis and it's an oral drug that basically treats clotting. So if you actually ever ask anybody, if they got clots from their shots, they would show up and they would say, oh no, we've got you covered. And they're on this very expensive oral product which is patented. Again, Pfizer is benefiting from that.